Ticker,Title,Link
EXEL,Exelixis (EXEL) Receives a Buy from Wells Fargo,8/12/2024 11:19:20 AM
EXEL,Exelixis: Balancing Strong Financials with Operational Challenges in Berens’s Hold Rating,8/9/2024 9:55:54 AM
EXEL,"Analysts’ Top Healthcare Picks: Pliant Therapeutics (PLRX), Exelixis (EXEL)",8/8/2024 10:41:40 AM
EXEL,Exelixis Buy Rating Affirmed on Strong Q2 Performance and Promising Pipeline Prospects,8/7/2024 1:29:58 PM
EXEL,"EXEL Stock Earnings: Exelixis Beats EPS, Beats Revenue for Q2 2024",8/6/2024 11:52:47 PM
EXEL,Exelixis Q2 2024 Earnings Preview,8/5/2024 9:35:33 PM
EXEL,"Earnings week ahead: Disney, Duke Energy, Palantir, Shopify, Uber and more",8/4/2024 12:00:00 PM
EXEL,Oppenheimer Remains a Buy on Exelixis (EXEL),7/30/2024 11:46:33 AM
EXEL,Exelixis Buy Rating Affirmed on Q2 Outperformance and Positive Litigation Outlook,7/25/2024 4:25:28 AM
EXEL,Morgan Stanley Sticks to Their Hold Rating for Exelixis (EXEL),7/12/2024 12:27:39 PM
EXEL,Bank of America Securities Reaffirms Their Buy Rating on Exelixis (EXEL),7/10/2024 1:18:05 PM
EXEL,7 Cheap Biotech Stocks With Major Upside Potential,7/9/2024 10:00:00 AM
EXEL,Ipsen Expands Exelixis Collaboration For Cabometyx In Advanced Neuroendocrine Tumors ,7/2/2024 7:39:44 AM
EXEL,Wall Street Analysts Are Bullish on Top Healthcare Picks,5/20/2024 11:21:02 PM
EXEL,Exelixis files patent suit against India’s Cipla over Cabometyx generics,5/11/2024 7:23:49 PM
EXEL,MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths',5/10/2024 9:08:04 PM
EXEL,Just Say No to Drugs: 3 Pharma Stocks to Avoid,5/8/2024 2:30:00 PM
EXEL,Buy Rating Affirmed for Exelixis Amid Solid Revenue and Strategic Growth Initiatives,5/3/2024 10:26:51 AM
EXEL,"Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Atricure (ATRC) and Glaukos (GKOS)",5/2/2024 12:18:05 PM
EXEL,The Analyst Verdict: Exelixis In The Eyes Of 5 Experts,5/1/2024 8:01:10 PM
EXEL,Exelixis down 7% as Q1 financial results disappoint,4/30/2024 11:20:17 PM
EXEL,Exelixis Q1 2024 Earnings Preview,4/29/2024 9:20:42 PM
EXEL,The Top 3 Biotech Stocks to Buy in April 2024,4/27/2024 11:00:00 AM
EXEL,Exelixis slips as Barclays downgrades on lack of catalysts,4/11/2024 2:10:03 PM
EXEL,What Analysts Are Saying About Exelixis Stock,4/10/2024 7:00:36 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: Surrozen (SRZN), Exelixis (EXEL) and Axsome Therapeutics (AXSM)",4/9/2024 2:10:05 AM
EXEL,Top buy-rated stocks and sell-rated stocks within Health Care - Citi,4/4/2024 3:12:55 PM
EXEL,3 Biotech Stocks to Buy on the Dip: March 2024,3/27/2024 5:07:58 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), IDEAYA Biosciences (IDYA) and Vor Biopharma (VOR)",3/21/2024 10:20:54 AM
EXEL,Cantor sees strong year ahead for oncology M&A,3/10/2024 5:08:00 PM
EXEL,3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success,3/6/2024 9:45:00 PM
EXEL,Truist Financial Keeps Their Buy Rating on Exelixis (EXEL),2/26/2024 12:17:17 PM
EXEL,Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying,2/23/2024 2:25:03 PM
EXEL,The 3 Best Biotech Stocks to Buy in February 2024,2/13/2024 1:00:00 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), BeiGene (BGNE) and Catalent (CTLT)",2/12/2024 1:20:16 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Neurocrine (NBIX) and Exelixis (EXEL)",2/8/2024 12:50:22 PM
EXEL,Exelixis Earns Buy Rating on Strong Financials and Positive Outlook,2/7/2024 2:25:27 PM
EXEL,"Exelixis Non-GAAP EPS of $0.33 beats by $0.02, revenue of $480M beats by $2.08M",2/6/2024 9:11:08 PM
EXEL,Notable earnings after Tuesday's close,2/5/2024 10:35:34 PM
EXEL,Pharma giants turn to China in search of targeted cancer drugs,2/4/2024 5:00:49 PM
EXEL,"Analysts Conflicted on These Healthcare Names: Exelixis (EXEL), Revvity (RVTY) and Becton Dickinson (BDX)",2/2/2024 1:10:22 PM
EXEL,Breaking Down Exelixis: 7 Analysts Share Their Views,1/30/2024 2:00:52 PM
EXEL,Exelixis Buy Rating: Balancing IP Confidence and Operating Leverage with Clinical Trial Skepticism,1/26/2024 1:37:43 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Kura Oncology (KURA) and Exelixis (EXEL)",1/25/2024 12:10:53 PM
EXEL,Piper Sandler Keeps Their Buy Rating on Exelixis (EXEL),1/23/2024 12:37:31 PM
EXEL,3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024,1/21/2024 6:16:40 PM
EXEL,3 Pharma Stocks Could Be the Pills Your Portfolio Needs,1/18/2024 9:00:00 PM
EXEL,"Jim Cramer Likes This 'Well-Run' Airline, Says This Entertainment Stock Has 'Balance Sheet From Hell'",1/12/2024 2:47:50 PM
EXEL,Exelixis Hold Rating Maintained Amid Cost-Cutting and Uninspiring Pipeline Outlook,1/11/2024 6:27:03 AM
EXEL,Buy Rating for Exelixis: Strategic Expansion and Strong Fiscal Discipline Signal Growth Potential,1/10/2024 12:16:33 PM
EXEL,Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?,1/8/2024 8:12:24 PM
EXEL,RBC Capital Reaffirms Their Buy Rating on Exelixis (EXEL),1/6/2024 1:46:52 AM
EXEL,Exelixis (EXEL) Receives a Sell from Goldman Sachs,1/4/2024 12:55:33 AM
EXEL,BTIG Remains a Buy on Exelixis (EXEL),1/2/2024 2:19:50 PM
EXEL,BTIG Sticks to Their Buy Rating for Exelixis (EXEL),12/31/2023 10:11:57 AM
EXEL,Wells Fargo Reaffirms Their Buy Rating on Exelixis (EXEL),12/19/2023 12:26:46 PM
EXEL,Exelixis’s Expansion and Innovation: A Measured Hold Amidst Promising Developments and Pending Validation,12/15/2023 8:36:42 AM
EXEL,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rain Therapeutics (RAIN), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL)",12/14/2023 1:51:32 PM
EXEL,6 Analysts Have This to Say About Exelixis,12/13/2023 8:00:38 PM
EXEL,Stifel Nicolaus Sticks to Its Hold Rating for Exelixis (EXEL),12/5/2023 12:28:31 PM
EXEL,"Exelixis, Arcus Biosciences Enter Clinical Trial Collaboration - Quick Facts ",12/4/2023 2:24:26 PM
EXEL,Piper Sandler Sticks to Their Buy Rating for Exelixis (EXEL),11/13/2023 12:19:18 PM
EXEL,Exelixis Announces Encouraging Results From Phase 1b Trial Of Zanzalintinib In Kidney Cancer ,11/10/2023 3:29:15 PM
EXEL,Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures,11/9/2023 9:43:11 PM
EXEL,3 Biotech Stocks With the Strongest Clinical Pipelines,11/8/2023 10:24:05 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Shockwave Medical (SWAV) and Exelixis (EXEL)",11/7/2023 1:20:52 PM
EXEL,"Analysts Have Conflicting Sentiments on These Healthcare Companies: InflaRx (IFRX), Exelixis (EXEL) and Humana (HUM)",11/6/2023 6:50:14 AM
EXEL,Where Exelixis Stands With Analysts,11/2/2023 8:00:45 PM
EXEL,Exelixis is about to announce earnings — here's what Wall Street expects,10/31/2023 3:01:13 PM
EXEL,"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Exelixis (EXEL) and Tenaya Therapeutics (TNYA)",10/27/2023 11:32:12 AM
EXEL,"Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Progyny (PGNY) and Exelixis (EXEL)",10/25/2023 11:40:44 AM
EXEL,"Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), American Well (AMWL) and Merck & Company (MRK)",10/21/2023 1:31:39 PM
EXEL,14 Analysts Have This to Say About Exelixis,10/11/2023 9:00:38 PM
EXEL,RBC Capital Sticks to Its Buy Rating for Exelixis (EXEL),10/6/2023 1:47:43 AM
EXEL,Steady Eddies: 3 Low Beta Stocks for Long-Haul Gains,10/2/2023 1:49:06 PM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023",9/26/2023 5:01:15 PM
EXEL,3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall,9/20/2023 6:15:34 PM
EXEL,The Latest Analyst Ratings for Exelixis,9/13/2023 6:00:26 PM
EXEL,Exelixis inks licensing deal with Insilico for tumor candidate,9/12/2023 5:05:23 PM
EXEL,Wells Fargo Sticks to Its Buy Rating for Exelixis (EXEL),9/11/2023 9:15:44 AM
EXEL,"Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest",8/24/2023 8:46:37 PM
EXEL,Where Exelixis Stands With Analysts,8/22/2023 3:00:16 PM
EXEL,These Are the ONLY 3 Biotech Stocks to Consider in August 2023,8/21/2023 8:20:38 PM
EXEL,3 Biotech Stocks You’ll Regret Not Buying Soon,8/9/2023 3:37:39 AM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023",8/8/2023 5:00:34 PM
EXEL,Exelixis (EXEL) Gets a Buy from Truist Financial,8/7/2023 2:26:54 AM
EXEL,"Analysts’ Top Healthcare Picks: Amneal Pharmaceuticals (AMRX), CVS Health (CVS)",8/3/2023 9:31:02 AM
EXEL,Analyst Expectations for Exelixis's Future,8/2/2023 8:00:28 PM
EXEL,"Exelixis Non-GAAP EPS of $0.31 beats by $0.09, revenue of $469.85M beats by $25.02M",8/1/2023 8:11:41 PM
EXEL,Exelixis Q2 2023 Earnings Preview,7/31/2023 9:35:53 PM
EXEL,Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil,7/29/2023 1:08:21 PM
EXEL,"Analysts Conflicted on These Healthcare Names: Exelixis (EXEL), HCA Healthcare (HCA) and Regeneron (REGN)",7/28/2023 9:20:31 AM
EXEL,Bank of America Securities Keeps Their Buy Rating on Exelixis (EXEL),7/26/2023 10:45:06 PM
EXEL,Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY) and Exelixis (EXEL),7/24/2023 11:00:50 PM
EXEL,The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023,7/20/2023 12:08:14 PM
EXEL,JMP Securities Keeps Their Buy Rating on Exelixis (EXEL),7/19/2023 4:35:07 AM
EXEL,RBC Capital Sticks to Its Buy Rating for Exelixis (EXEL),7/11/2023 1:47:01 AM
EXEL,Bank of America Securities Reaffirms Their Buy Rating on Exelixis (EXEL),6/22/2023 9:25:15 AM
EXEL,Stifel Nicolaus Remains a Hold on Exelixis (EXEL),6/7/2023 2:06:52 AM
EXEL,Exelixis sees three Farallon nominees elected to board,6/1/2023 11:58:37 AM
EXEL,Stifel Nicolaus Sticks to Their Hold Rating for Exelixis (EXEL),5/30/2023 2:06:47 AM
EXEL,Exelixis (EXEL) Gets a Hold from Stifel Nicolaus,5/25/2023 2:07:02 AM
EXEL,"Catalyst watch: Eyes on Ford event, Virgin Galactic launch, Nvidia earnings and Microsoft conference",5/19/2023 7:00:19 PM
EXEL,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Exelixis (EXEL), Masimo (MASI) and Reata Pharmaceuticals (RETA)",5/17/2023 2:10:42 AM
EXEL,RBC Capital Keeps Their Buy Rating on Exelixis (EXEL),5/12/2023 1:45:37 AM
EXEL,8 Analysts Have This to Say About Exelixis,5/10/2023 6:01:57 PM
EXEL,"Exelixis Non-GAAP EPS of $0.16 misses by $0.06, revenue of $408.8M misses by $13.86M",5/9/2023 8:12:41 PM
EXEL,Exelixis Q1 2023 Earnings Preview,5/8/2023 9:35:45 PM
EXEL,Exelixis holder Farallon files definitive materials in proxy battle,5/3/2023 6:22:12 PM
EXEL,EF Hutton Reaffirms Their Buy Rating on Exelixis (EXEL),4/28/2023 12:36:22 PM
EXEL,Exelixis (EXEL) Receives a Sell from Goldman Sachs,4/27/2023 12:25:05 AM
EXEL,JMP Securities Sticks to Their Buy Rating for Exelixis (EXEL),4/21/2023 4:15:07 AM
EXEL,Exelexis supports two of Farallon's board nominees as it faces proxy fight,4/13/2023 9:16:58 PM
EXEL,What 9 Analyst Ratings Have To Say About Exelixis,4/12/2023 10:01:12 PM
EXEL,RBC Capital Remains a Buy on Exelixis (EXEL),4/8/2023 1:46:02 AM
EXEL,Exelixis faces proxy battle with investor Farallon Capital (update),4/6/2023 1:03:00 AM
EXEL,Exelixis responds to Farallon Capital letter,4/5/2023 11:46:05 PM
EXEL,Exelixis shareholder Farallon to nominate three to biotech's board,3/27/2023 9:50:01 PM
EXEL,"Large Exelixis shareholder Farallon calls biotech undervalued, needs board refresh",3/20/2023 9:33:07 PM
EXEL,The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector,3/15/2023 3:31:39 PM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023",3/9/2023 4:00:39 PM
EXEL,The Latest Analyst Ratings for Exelixis,3/3/2023 6:01:16 PM
EXEL,Exelixis Cabometyx + Tecentriq late-stage trial fails in advanced kidney cancer,3/2/2023 11:00:45 PM
EXEL,Analysts Have Conflicting Sentiments on These Services Companies: Exelixis (EXEL) and Restaurant Brands International (QSR),2/14/2023 4:30:31 PM
EXEL,Exelixis to pay $35M in milestone as FDA clears trial for cancer drug,2/13/2023 6:55:36 PM
EXEL,"Analysts Conflicted on These Services Names: Exelixis (EXEL), MGM Resorts (MGM) and Criteo SA (CRTO)",2/9/2023 12:03:04 PM
EXEL,Barclays Sticks to Its Buy Rating for Exelixis (EXEL),2/8/2023 5:35:12 PM
EXEL,"Exelixis, Inc. Q4 Earnings Summary",2/7/2023 10:41:25 PM
EXEL,Exelixis Q4 2022 Earnings Preview,2/6/2023 10:35:45 PM
EXEL,Credit Suisse Says These 2 Stocks Could Surge Over 30% From Current Levels,2/2/2023 12:46:39 AM
EXEL,"Exelixis rated outperform at Credit Suisse on success of Cabometyx, pipeline",1/26/2023 4:08:40 PM
EXEL,"Exelixis' Patent Decision In Line With Expectations, But Analysts Say Stock Overhang Could Continue",1/20/2023 7:21:04 PM
EXEL,7 Biotech Stocks That Will Make You Rich in 10 Years,1/18/2023 8:44:49 PM
EXEL,6 Analysts Have This to Say About Exelixis,1/11/2023 2:00:29 PM
EXEL,Exelixis sees Q4 revenue revenue of $415M and issues FY23 guidance,1/9/2023 7:38:47 AM
EXEL,RBC Capital Remains a Buy on Exelixis (EXEL),1/7/2023 1:46:07 AM
EXEL,JMP Securities Remains a Buy on Exelixis (EXEL),1/5/2023 5:15:13 AM
EXEL,7 Undervalued Biotech Stocks to Buy Before They Boom,12/29/2022 4:30:22 PM
EXEL,Exelixis starts phase 3 trial of zanzalintinib/Opdivo combo for kidney cancer,12/22/2022 2:34:26 PM
EXEL,Exelixis makes two scientific executive changes,12/15/2022 11:08:06 PM
EXEL,What 5 Analyst Ratings Have To Say About Exelixis,12/9/2022 5:02:47 PM
EXEL,JMP Securities Reaffirms Their Buy Rating on Exelixis (EXEL),11/4/2022 5:05:56 AM
EXEL,What 4 Analyst Ratings Have To Say About Exelixis,11/2/2022 8:16:43 PM
EXEL,Exelixis brokers two collaboration deals on peptide-drug conjugate and monoclonal antibody,11/1/2022 9:22:19 PM
EXEL,Here's what Wall Street expects from Exelixis's earnings,10/31/2022 3:01:13 PM
EXEL,BMO Capital Sticks to Their Buy Rating for Exelixis (EXEL),10/27/2022 1:36:08 PM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022",10/18/2022 4:21:58 PM
EXEL,Jefferies Keeps Their Buy Rating on Exelixis (EXEL),10/13/2022 12:35:47 PM
EXEL,These 7 Biotech Stocks Are Set to Boom in 2023,10/10/2022 10:15:48 AM
EXEL,Exelixis Expands Agreement With Bristol Myers For STELLAR-002 Trial - Quick Facts ,10/4/2022 2:25:03 PM
EXEL,3 Biotech Stocks to Buy Now for Extraordinary Gains,9/21/2022 1:16:12 AM
EXEL,The 7 Best Biotech Stocks to Buy,9/20/2022 5:45:25 PM
EXEL,"Exelixis, Teva fight over Cabometyx generic again",9/6/2022 1:01:18 PM
EXEL,Why did Exelixis stock slip today?,8/10/2022 8:29:35 PM
EXEL,"Exelixis Non-GAAP EPS of $0.28 beats by $0.04, revenue of $419.43M beats by $26.42M",8/9/2022 8:09:46 PM
EXEL,Notable earnings after Tuesday's close,8/8/2022 9:35:42 PM
EXEL,Exelixis again sues MSN Pharmaceuticals over Cabometyx generic,7/19/2022 10:23:03 PM
EXEL,Exelixis says phase 3 trial evaluating its kidney cancer combo treatment met main goal,7/11/2022 1:54:20 PM
EXEL,"The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill",7/7/2022 4:03:38 PM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022",6/24/2022 5:17:22 PM
EXEL,Recap of Tuesday's Biotech Catalysts - End of the Day Summary,6/21/2022 11:38:14 PM
EXEL,"The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK",6/16/2022 4:09:44 PM
EXEL,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday,5/24/2022 11:29:47 AM
EXEL,Exelixis drops quickly on day four of Cabometyx patent trial (update),5/19/2022 5:08:44 PM
EXEL,Exelixis Q1 net income surges nearly 42 times higher on strong Cabometyx sales,5/10/2022 10:59:37 PM
EXEL,Exelixis Q1 2022 Earnings Preview,5/9/2022 9:35:28 PM
EXEL,"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",5/3/2022 3:01:06 PM
EXEL,7 Top-Rated Biotech Stocks to Buy for Q2,4/21/2022 11:29:16 AM
EXEL,Exelixis begins phase 1 trial of XL114 to treat non-hodgkin’s lymphoma,4/14/2022 3:03:27 PM
EXEL,"The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial",3/15/2022 12:46:20 PM
EXEL,"Incannex Healthcare, GitLab lead postmarket gainers; Coupa Software top loser",3/14/2022 9:00:09 PM
EXEL,Judge rejects MSN motion to add more patents to Exelixis Cabometyx patent suit,2/25/2022 8:48:01 PM
EXEL,"Exelixis beats on top and bottom lines, and analysts like what they see (EXEL)",2/18/2022 6:29:08 PM
EXEL,"Exelixis Non-GAAP EPS of $0.35 beats by $0.19, revenue of $451.14M beats by $94.19M",2/17/2022 9:09:23 PM
EXEL,Exelixis Q4 2021 Earnings Preview,2/16/2022 10:35:47 PM
EXEL,Exelixis/Bristol-Myers' drug combo shows sustained survival benefits in kidney cancer,2/15/2022 11:36:33 AM
EXEL,Exelixis Cabometyx combos show promise for colorectal cancer,1/19/2022 6:20:43 PM
EXEL,A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Up 0.5%,1/10/2022 11:51:51 AM
EXEL,7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now,1/3/2022 7:14:06 PM
EXEL,"The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review",12/23/2021 1:29:47 PM
EXEL,Exelixis initiates Phase 1b XL092 combo trial in solid tumors,12/15/2021 1:26:51 PM
EXEL,Analyst Ratings For Exelixis,11/3/2021 5:43:59 PM
EXEL,SAVA Stock: 8 Things to Know as Cassava Sciences Rockets Higher,11/2/2021 9:20:43 PM
EXEL,Notable earnings after Tuesday's close,11/1/2021 9:35:55 PM
EXEL,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",10/31/2021 7:23:54 PM
EXEL,"Exelixis, STORM Collaborate To Discover And Advance Novel Drug Leads Intended For Cancer Treatment ",10/14/2021 2:16:19 PM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021",10/7/2021 4:02:38 PM
EXEL,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 2%,9/20/2021 12:02:00 PM
EXEL,Exelixis Presents Results Of Cabozantinib On Metastatic Castration-Resistant Prostate Cancer ,9/18/2021 4:31:06 PM
EXEL,Exelixis Reports Positive Data From Post-hoc Exploratory Analysis Of Phase 3 CheckMate -9ER Trial ,9/16/2021 9:30:12 AM
EXEL,Exelixis Says Two Senior Executives Passed Away ,9/7/2021 5:31:49 AM
EXEL,7 Best Biotech Stocks to Buy in 2021 with Huge Upside,8/25/2021 4:08:19 PM
EXEL,"Exelixis, Invenra Announce Expanded Collaboration - Quick Facts ",8/16/2021 2:14:25 PM
EXEL,"Exelixis EPS beats by $0.24, beats on revenue",8/5/2021 8:08:31 PM
EXEL,Notable earnings after Thursday's close,8/4/2021 9:35:49 PM
EXEL,Exelixis earnings: here's what to expect,8/3/2021 3:02:13 PM
EXEL,"The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street",7/20/2021 2:19:56 PM
EXEL,"The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study",7/16/2021 1:37:29 PM
EXEL,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",7/15/2021 2:07:56 PM
EXEL,"The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO",7/9/2021 1:36:16 PM
EXEL,"The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test",7/8/2021 1:45:17 PM
EXEL,"The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs",6/30/2021 1:28:56 PM
EXEL,"The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout",6/29/2021 2:17:44 PM
EXEL,Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher,6/28/2021 8:40:48 PM
EXEL,"The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus",6/27/2021 6:55:52 PM
EXEL,Exelixis CMO Gisela Schwab begins medical leave of absence,6/18/2021 12:48:23 PM
EXEL,"Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021",6/15/2021 4:24:55 PM
EXEL,"Exelixis, Bristol Myers To Evaluate XL092-Immuno-oncology Therapies In Advanced Solid Tumors ",6/14/2021 2:34:07 PM
EXEL,"The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal",5/25/2021 1:53:39 PM
EXEL,Exelixis slips as expanded cohort in cancer trial shows a lower objective response rate,5/24/2021 8:36:07 PM
EXEL,Ipsen partners with Exelixis to develop Cabometyx for thyroid cancer,5/12/2021 12:36:17 PM
EXEL,Exelixis Q1 Earnings Preview,5/5/2021 9:35:59 PM
EXEL,Here's what to expect from Exelixis's earnings,5/4/2021 3:02:12 PM
EXEL,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",4/15/2021 1:49:24 PM
EXEL,Exelixis Says FDA Accepts IND For XB002 In Patients With Advanced Solid Tumors - Quick Facts ,4/5/2021 2:22:36 PM
EXEL,Exelixis’ partner Ipsen win EU approval for Cabometyx combo in  kidney cancer,3/31/2021 7:08:45 PM
EXEL,"Pfizer, Merck KGaA and Exelixis to collaborate in bladder cancer trial",3/18/2021 12:32:16 PM
EXEL,Exelixis enters WuXi Biologics deal in oncology pipeline push,3/8/2021 4:36:36 PM
EXEL,Bristol Myers' opdivo combo wins positive opinion from EU in kidney cancer,2/26/2021 11:59:05 AM
EXEL,Exelixis' CABOMETYX wins FDA's breakthrough therapy status,2/25/2021 1:36:46 PM
EXEL,Exelixis’ oral therapy shows positive effect in kidney cancer,2/16/2021 11:58:01 AM
EXEL,"The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs",2/10/2021 1:34:43 PM
EXEL,Exelixis Q4 Earnings Preview,2/9/2021 10:35:52 PM
EXEL,"The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight",2/6/2021 6:42:05 PM
EXEL,Exelixis starts early-stage study with XL102 in solid tumors,1/25/2021 1:33:24 PM
EXEL,Exelixis' CABOMETYX-OPDIVO combo wins FDA approval for renal cell carcinoma,1/22/2021 7:36:14 PM
EXEL,"Exelixis expects FY20 product revenue of $741, sees FY21 revenue as high as $1.05B",1/11/2021 7:26:50 AM
EXEL,Exelixis's cabozantinib shows PFS benefit in late-stage thyroid cancer study,12/21/2020 1:56:17 PM
EXEL,Exelixis exercises option for XL102 from Dr. Reddy's Aurigene,12/7/2020 3:35:57 PM
EXEL,"Exelixis nabs rights to antibody-drug conjugate, clinical development to start next quarter",12/2/2020 2:38:05 PM
EXEL,Exelixis Says Takeda Receives Approval For Cabometyx In Japan - Quick Facts ,11/27/2020 2:20:37 PM
EXEL,"Exelixis EPS beats by $0.03, beats on revenue",11/5/2020 9:09:07 PM
EXEL,Notable earnings after Thursday's close,11/4/2020 10:35:58 PM
EXEL,Takeda submits supplemental application for Cabometyx + Opdivo for kidney cancer in Japan,10/27/2020 5:38:43 AM
EXEL,Exelixis launches XL092 combination cohort in early-stage solid tumor study,10/26/2020 1:19:03 PM
EXEL,FDA OKs accelerated review for Opdivo/Cabometyx combo for kidney cancer,10/19/2020 11:10:42 AM
EXEL,Exelixis/Aurigene AUR102 shows promising action in cancer therapy,10/9/2020 10:51:30 AM
EXEL,Here's what Wall Street expects from Exelixis's earnings,8/5/2020 3:04:13 PM
EXEL,Stock Alert: Exelixis Up 4% ,7/10/2020 4:18:22 PM
EXEL,Exelixis launches late-stage study of Cabometyx combo in lung cancer,6/11/2020 1:31:48 PM
EXEL,"Exelixis EPS beats by $0.02, beats on revenue",5/5/2020 8:10:21 PM
EXEL,Exelixis earnings preview: what to expect,5/4/2020 3:01:31 PM
EXEL,"CYCC In STOPCOVID, EXEL Hits New High, NVS Trialing Malaria Drug For COVID-19 ",4/21/2020 7:39:42 AM
EXEL,"IVR, NVAX, SRG and EXEL among midday movers",4/20/2020 4:40:42 PM
EXEL,Stock Alert: Exelixis Shares Up 13% In Pre-Market ,3/25/2020 11:58:02 AM
EXEL,"TOL, SDC among premarket losers",2/26/2020 2:17:31 PM
EXEL,"Exelixis EPS beats by $0.05, misses on revenue",2/25/2020 9:07:18 PM
EXEL,Exelixis earnings: here's what Wall Street expects,2/24/2020 3:01:36 PM
EXEL,3 Mid-Cap Growth Stocks to Buy,2/12/2020 7:10:26 PM
EXEL,Exelixis' cabozantinib combo shows encouraging action in prostate cancer,2/11/2020 12:40:03 PM
EXEL,Key events next week - healthcare,2/7/2020 2:47:42 PM
EXEL,Stock Alert: Exelixis On The Move ,2/5/2020 5:01:30 PM
EXEL,7 Under-The-Radar Growth Stocks That Could Benefit New Investors,10/14/2019 4:08:25 PM
EXEL,"10 Small-Cap, Up-And-Coming Stocks to Keep on Your Radar",8/21/2019 4:55:36 PM
EXEL,8 Biotech Stocks to Watch After the Q2 Earnings Season,8/20/2019 5:06:30 PM
EXEL,"AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… ",8/1/2019 10:04:07 AM
EXEL,Here's what Wall Street expects from Exelixis's earnings report,7/29/2019 3:02:47 PM
EXEL,Exelixis earnings: here's what to expect,4/29/2019 3:02:38 PM
EXEL,Exelixis is about to announce its earnings — here's what Wall Street expects,2/10/2019 3:01:47 PM
EXEL,"First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch ",1/15/2019 7:38:34 AM
EXEL,9 Pharma Stocks To Watch This Month ,1/11/2019 10:30:26 AM
EXEL,Biotech Stocks Facing FDA Decision In January 2019 ,12/24/2018 11:13:44 AM
EXEL,Exelixis earnings preview: what Wall Street is expecting,10/30/2018 3:03:29 PM
EXEL,Exelixis earnings preview: what Wall Street is expecting,7/30/2018 3:02:46 PM
EXEL,Copart To Replace Dr Pepper Snapple Group In S&P 500 ,6/26/2018 4:50:07 AM
EXEL,"AKER Withdraws 510(K), TTOO Turns Head, CPRX, LOXO To Face FDA In Nov. ",5/30/2018 7:13:11 AM
EXEL,Exelixis To Get $50 Mln As Ipsen Gets Expanded EC Approval For CABOMETYX ,5/17/2018 7:28:17 AM
EXEL,BRIEF-Exelixis Says Phase 3 Imblaze370 Study Did Not Meet Its Primary Endpoint Of Improving Overall Survival Vs Regorafenib,5/10/2018 7:10:32 AM
EXEL,BRIEF-Exelixis Says CEO Michael Morrissey's FY 2017 Total Compensation Was $9.4 Mln VS $6.3 Mln,4/12/2018 3:56:47 PM
EXEL,BRIEF-Exelixis Says Board Increased Size Of Board To 12 Members,4/9/2018 11:31:13 PM
EXEL,BRIEF-Exelixis Says Ipsen received validation of the application for variation to the Cabometyx,3/28/2018 7:15:55 AM
EXEL,"TTPH Implodes On IGNITE3, EC Approves 2nd Herceptin Biosimilar, PTIE At It Again ",2/14/2018 7:32:45 AM
EXEL,"EIGR Disappoints, EXEL's CELESTIAL Excels, JUNO In CELG's Crosshairs? ",1/17/2018 8:06:38 AM
EXEL,"EXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours ",12/20/2017 6:11:11 AM
EXEL,"Pfizer, Exelixis cancer drugs get FDA approval for wider use (PFE, EXEL)",12/19/2017 10:52:03 PM
EXEL,"First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675 ",11/22/2017 7:19:41 AM
EXEL,"NBIX Delivers, MNTA's Biosimilar Drug Trial Fails, No FDA Panel Meet For RARE ",11/2/2017 7:37:43 AM
EXEL,BRIEF-Exelixis reports Q3 earnings per share $0.26 (EXEL),11/1/2017 9:47:19 PM
EXEL,"HIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL ",10/17/2017 3:48:40 AM
EXEL,Exelixis Remains Sharply Higher After Early Rally ,10/16/2017 8:19:44 PM
EXEL,"Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes ",9/25/2017 4:36:05 AM
EXEL,"BRIEF-Ipsen and Exelixis announce Phase 2 results of CABOSUN trial (IPN, EXEL)",9/11/2017 8:02:03 AM
EXEL,"NLNK Rallies On Indoximod Data, VRNA Breathes Easy, ALNY Jolted ",9/8/2017 4:57:32 AM
EXEL,"Stock Performance Review on Biotech Industry -- Exelixis, Geron, Inovio Pharma, and Intra Cellular Therapies",8/28/2017 1:10:00 PM
EXEL,BRIEF-Exelixis submits U.S. Supplemental New Drug Application for Cabometyx for the treatment of advanced kidney cancer (EXEL),8/16/2017 1:22:03 PM
EXEL,"Technical Snapshots for These Biotech Stocks -- Exelixis, Celldex Therapeutics, Clovis Oncology, and Geron",7/24/2017 12:40:00 PM
EXEL,BRIEF-Exelixis announces settlement of dispute with Genentech (EXEL),7/20/2017 1:54:03 PM
EXEL,Company Spotlight: Exelixis ,7/14/2017 3:13:24 PM
EXEL,"BRIEF-Exelixis, Bristol-Myers Squibb initiate phase 3 trial (BMY, EXEL, IPN)",7/10/2017 3:06:03 PM
EXEL,Biopharma Stock Breakouts With Significant Developments and Market Activity,6/21/2017 6:15:00 PM
EXEL,"AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade ",6/20/2017 8:08:53 AM
EXEL,BRIEF-Exelixis announces initiation of early-stage trial of combination drug (EXEL),6/12/2017 4:18:03 PM
EXEL,"Investors: Covered Call reports for Exelixis, Facebook, Priceline, Pfizer Inc. and AT&T include trade ideas that offer returns of 18% or more!",5/2/2017 3:31:00 PM
EXEL,BRIEF-Exelixis Q1 earnings per share $0.05 (EXEL),5/1/2017 10:56:07 PM
EXEL,BRIEF-Exelixis further reduces indebtedness by repaying Silicon Valley Bank term loan (EXEL),3/29/2017 11:40:52 PM
EXEL,"Biotech Stocks Under Scanner -- Gilead Sciences, Exelixis, Mast Therapeutics, and Novavax",3/14/2017 1:35:00 PM
EXEL,"Beat market volatility with these stock option trade ideas for Citigroup, Exelixis, Gilead Sciences, Tesla Motors, and US Oil Fund!",3/9/2017 3:31:00 PM
EXEL,BRIEF-Exelixis' cabozantinib granted orphan drug designation (EXEL),3/6/2017 3:26:03 PM
EXEL,New Cancer Therapeutics Drive the Cancer Biological Therapy Market,2/27/2017 3:00:00 PM
EXEL,BRIEF-Exelixis announces phase 1 trial results for cabozantinib in combination with nivolumab with or without ipilimumab (EXEL),2/17/2017 11:30:13 PM
EXEL,"BRIEF-Exelixis and Takeda enter into exclusive licensing agreement (EXEL, 4502)",1/31/2017 12:46:09 AM
EXEL,BRIEF-Exelixis announces Q3 and YTD 2016 financial results (EXEL),11/3/2016 11:58:18 PM
EXEL,BRIEF-Exelixis announces positive results from phase 2 CABOSUN trial of Cabozantinib vs Sunitinib (EXEL),10/11/2016 6:50:21 PM
EXEL,"UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial (EXEL, PFE, IPN)",10/10/2016 3:30:20 PM
EXEL,BRIEF-Exelixis elects Julie Anne Smith to board (EXEL),9/26/2016 2:30:23 PM
